M
Maureen E. Trudeau
Researcher at Sunnybrook Health Sciences Centre
Publications - 259
Citations - 14303
Maureen E. Trudeau is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 51, co-authored 235 publications receiving 12424 citations. Previous affiliations of Maureen E. Trudeau include York University & Women's College Hospital.
Papers
More filters
Journal ArticleDOI
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
Rebecca Dent,Maureen E. Trudeau,Kathleen I. Pritchard,Wedad Hanna,Harriet K. Kahn,Carol Sawka,Lavina Lickley,Ellen Rawlinson,Ping Sun,Steven A. Narod +9 more
TL;DR: Triple-negative breast cancers have a more aggressive clinical course than other forms of breast cancer, but the adverse effect is transient.
Journal ArticleDOI
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Pamela J. Goodwin,Marguerite Ennis,Kathleen I. Pritchard,Maureen E. Trudeau,Jarley Koo,Yolanda Madarnas,Warren Hartwick,Barry Hoffman,Nicky Hood +8 more
TL;DR: Fasting insulin was associated with distant recurrence and death; the hazard ratios and 95% confidence intervals (CI) for those in the highest (> 51.9 pmol/L) versus the lowest (< 27.0 pmol /L) insulin quartile were 2.0 (95% CI, 1.2 to 3.3) and 3.1 (95%) respectively.
Journal ArticleDOI
Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.
Anthony Fyles,David R. McCready,Lee Manchul,Maureen E. Trudeau,Patricia Merante,Melania Pintilie,Lorna Weir,Ivo A. Olivotto +7 more
TL;DR: Radiotherapy plus tamoxifen significantly reduces the risk of breast and axillary recurrence after lumpectomy in women with small, node-negative, hormone-receptor-positive breast cancers.
Journal ArticleDOI
Risk of Menopause During the First Year After Breast Cancer Diagnosis
TL;DR: Age and systemic chemotherapy are the strongest predictors of menopause in women with locoregional breast cancer as well as planned adjuvant treatment, and it may facilitate clinical decision-making.
Journal ArticleDOI
Pattern of metastatic spread in triple-negative breast cancer
TL;DR: The excess risk of distant recurrence in triple-negative breast cancers, versus other forms of cancer, is attributable in large part to an excess of visceral metastases in the first five years following diagnosis.